Minerva Neurosciences, Inc. (NERV) NASDAQ
5.28
-0.32(-5.71%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.28
-0.32(-5.71%)
Currency In USD
| Market Cap | 34.03M |
| Enterprise Value | 16.69M |
| P/E Ratio | -0.2 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -3 |
| Return On Equity | 5.07 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -5,442 |
| EBITDA | -15.1M |
| Net Income | -293.42M |
| Diluted EPS | -34.67 |
| Total Cash | 82.3M |
| Total Cash/Share | 7.4 |
| Total Debt | 64.96M |
| Total Debt/Equity | -0.48 |
| Current Ratio | 36.29 |
| Book Value Per Share | -12.66 |
| 52-Week Change | 242.86 |
| 52-Week High | 12.46 |
| 52-Week Low | 1.15 |
| Moving Average 50 Days | 6.09 |
| Moving Average 200 Days | 3.73 |
| Average Volume | 215,022 |
| Shares Outstanding | 6.99M |
| % Held by Institutions | 304.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | June 21, 2022 |